Claritev Corp (CTEV)
NYSE · Common · CUSIP 62548M209
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for CTEV and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
62548M209 (prev. 17144C203 )
Market Cap
Large Cap
Previous Symbol
MPLN (changed 10/9/2020)
Previous Name
MultiPlan Corp
Business: Claritev Corp is a healthcare technology, data and insights company focused on delivering affordability, transparency and quality to the U.S. healthcare system. Claritev leverages world-class technology and AI to power a robust enterprise platform that delivers meaningful insights to drive affordability and price transparency, and optimizes networks and benefits design in healthcare.
Notes: September 10, 2024 -- MultiPlan Corporation (“MultiPlan” or the “Company”) (NYSE: MPLN), a leading provider of technology and data-enabled cost management, payment, and revenue integrity solutions to the U.S. health care industry, today announced that it expects a 1-for-40 reverse stock split of its outstanding shares of Class A common stock (the “common stock”) will be effective as of September 20, 2024 at 5:00 p.m. Eastern Time. MultiPlan’s common stock will continue trading on the New York Stock Exchange (“NYSE”) under the existing symbol (MPLN) and will begin trading on a split-adjusted basis when the market opens on September 23, 2024, with the new CUSIP number 62548M209. <p> October 7, 2020 -- Churchill Capital Corp III (“Churchill III”) (NYSE: CCXX), a public investment vehicle, announced that in a special meeting held today, its stockholders voted to approve its combination with Polaris Parent Corp., the parent of MultiPlan, Inc. (“MultiPlan”), a leading value-added provider of data analytics and technology-enabled end-to-end cost management solutions to the U.S. healthcare industry, and related matters. Approximately 93% of the votes cast at the meeting, representing approximately 76% of Churchill III’s outstanding shares, voted to approve the business combination. The consummation of the business combination is currently expected to occur on or about October 8, 2020, subject to the satisfaction or waiver of applicable closing conditions. The combined company will be renamed MultiPlan Corporation, and it is anticipated that on October 9, 2020, the ticker symbol of its Class A common shares, which are listed on the New York Stock Exchange, will be changed to “MPLN”

Company Contact

CEO
Travis Dalton
CFO
Doug Gardis
Headquarters
7900 Tysons One Place, Suite 400, McLean, VA 22102
Phone
212-780-2000 · Toll-Free 866-909-7427
Investor Relations
Shawna Gasik · 866-909-7427 · investor@multiplan.com
SEC EDGAR Filings
View filings »
Find all related securities for CTEV »